Suppr超能文献

单个直径>5cm 的大肝细胞癌有手术指征:是否必须行肝叶切除术?一项倾向评分加权分析。

Single large hepatocellular carcinoma > 5 cm with surgical indication: is it mandatory a major hepatectomy? a propensity-score weighted analysis.

机构信息

Unit of hepatobiliopancreatic surgery, Department of General Surgery I, IRCCS San Gerardo dei Tintori, Milano-Bicocca University, Via Pergolesi 33, 20052, Monza, MB, Italy.

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

出版信息

Langenbecks Arch Surg. 2024 Aug 11;409(1):248. doi: 10.1007/s00423-024-03419-4.

Abstract

PURPOSE

Single large hepatocellular carcinoma >5cm (SLHCC) traditionally requires a major liver resection. Minor resections are often performed with the goal to reduce morbidity and mortality. Aim of the study was to establish if a major resection should be considered the best treatment for SLHCC or a more limited resection should be preferred.

METHODS

A multicenter retrospective analysis of the HE.RC.O.LE.S. Group register was performed. All collected patients with surgically treated SLHCC were divided in 5 groups of treatment (major hepatectomy, sectorectomy, left lateral sectionectomy, segmentectomy, non-anatomical resection) and compared for baseline characteristics, short and long-term results. A propensity-score weighted analysis was performed.

RESULTS

535 patients were enrolled in the study. Major resection was associated with significantly increased major complications compared to left lateral sectionanectomy, segmentectomy and non-anatomical resection (all p<0.05) and borderline significant increased major complications compared to sectorectomy (p=0.08). Left lateral sectionectomy showed better overall survival compared to major resection (p=0.02), while other groups of treatment resulted similar to major hepatectomy group for the same item. Absence of oncological benefit after major resection and similar outcomes among the 5 groups of treatment was confirmed even in the sub-population excluding patients with macrovascular invasion.

CONCLUSION

Major resection was associated to increased major post-operative morbidity without long-term survival benefit; when technically feasible and oncologically adequate, minor resections should be preferred for the surgical treatment of SLHCC.

摘要

目的

传统上,直径大于 5 厘米的单个大肝细胞癌(SLHCC)需要进行大肝切除术。小范围切除术通常是为了降低发病率和死亡率。本研究的目的是确定大切除术是否应被视为治疗 SLHCC 的最佳方法,还是应优先选择更有限的切除术。

方法

对 HE.RC.O.LE.S. 组注册中心进行了多中心回顾性分析。所有接受手术治疗的 SLHCC 患者均分为 5 组治疗(大肝切除术、节段切除术、左外叶切除术、肝段切除术、非解剖性切除术),并比较基线特征、短期和长期结果。进行倾向评分加权分析。

结果

共有 535 例患者入组。与左外叶切除术、肝段切除术和非解剖性切除术相比,大切除术与显著增加的主要并发症相关(均 p<0.05),与节段切除术相比,大切除术与显著增加的主要并发症相关(p=0.08)。左外叶切除术的总生存率优于大切除术(p=0.02),而其他治疗组的结果与大肝切除术组相似。即使在排除大血管侵犯患者的亚组中,大切除术无肿瘤获益且 5 组治疗结果相似的结论也得到了证实。

结论

大切除术与术后主要并发症发病率增加相关,无长期生存获益;在技术可行和肿瘤学充分的情况下,对于 SLHCC 的手术治疗,应优先选择小范围切除术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验